Madeleine Pharmaceuticals Competitors and Similar CompaniesClear all
Impel Pharmaceuticals's competitors and similar companies include Tonix Pharmaceuticals.
 Impel Pharmaceuticals Impel Pharmaceuticals (formerly known as Impel NeuroPharma) is a pharmaceutical company that develops and commercializes therapies for patients suffering from central nervous system diseases. |  Tonix Pharmaceuticals Tonix Pharmaceuticals develops pharmaceutical products for central nervous system disorders. | |
Founding Date | Founding Date 2008 | Founding Date 2007 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Seattle, US HQ | Locations Chatham, US HQ Montréal, CA Dublin, IE Dartmouth, US New York, US San Diego, US |
Employees | Employees 6710% increase | Employees 1633% increase |
Valuation ($) | Valuation ($) 5.8 m | Valuation ($) 23.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $12.7m (FY, 2022) | Revenue (est.) $13.1m (FY, 2025) |
Cost of goods | Cost of goods $6.5m (FY, 2022) | Cost of goods $6.6m (FY, 2025) |
Gross profit | Gross profit $6.2m (FY, 2022) | Gross profit $6.5m (FY, 2025) |
Net income | Net income ($106.3m) (FY, 2022) | Net income ($124m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 108.1m | Total funding raised $ 15.5m |
For sources of this data, please see the company profile
View Company Profiles
Tonix Pharmaceuticals
HQ
Chatham, US
Employees
16↑ 33% increase
Tonix Pharmaceuticals develops pharmaceutical products for central nervous system disorders.
View company